integMET
Home
About
Documentation
Diff Profiles
Metabolites
studies
Gragh
Metabolites
›
VKOLGTZUJRSPMQ-NZXTZBTJSA-N
1-tridecanoyl-2-(13Z,16Z-docosadienoyl)-glycero-3-phospho-(1'-myo-inositol)
VKOLGTZUJRSPMQ-NZXTZBTJSA-N
CHEBI:138557
0 Reactome links
1 studies
1
Observed studies
1
Observed diff profiles
0
Reactome pathways
Metabolite details
Identifier
VKOLGTZUJRSPMQ-NZXTZBTJSA-N
InChI Key
VKOLGTZUJRSPMQ-NZXTZBTJSA-N
IUPAC name
Preferred name
1-tridecanoyl-2-(13Z,16Z-docosadienoyl)-glycero-3-phospho-(1'-myo-inositol)
INN name
—
Synonym
PI(13:0/22:2(13Z,16Z))
ChEBI
CHEBI:138557
Reactome pathways
No Reactome pathways listed for this metabolite.
Observed in studies
Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide
Observed in differential profiles
Control_vs_OXPA_Treatment